2019
DOI: 10.1007/s11096-019-00860-0
|View full text |Cite
|
Sign up to set email alerts
|

Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 26 publications
0
10
0
1
Order By: Relevance
“…Patel et al. investigated adverse drug reactions to antineoplastic agents and the impact of clinical pharmacists in minimizing reactions, 18 which we did not assess directly. In a prospective study in France in which 489 adult cancer patients were admitted to a hematology/oncology department over one year, the pharmacists identified 552 drug-related problems which accounted for 12.6% of reviewed prescription.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patel et al. investigated adverse drug reactions to antineoplastic agents and the impact of clinical pharmacists in minimizing reactions, 18 which we did not assess directly. In a prospective study in France in which 489 adult cancer patients were admitted to a hematology/oncology department over one year, the pharmacists identified 552 drug-related problems which accounted for 12.6% of reviewed prescription.…”
Section: Discussionmentioning
confidence: 99%
“…Although several studies have evaluated the impact of pharmacists in general, the role of clinical pharmacists in oncology has been evaluated in a few studies. 1619 Most of these studies evaluated their roles in the outpatient settings, 17,1922 and only a few were conducted among inpatients. 16,18,23,24 Therefore, we evaluated the impact of clinical pharmacists’ interventions (CPIs) in patients admitted to the medical oncology service at a comprehensive cancer center.…”
Section: Introductionmentioning
confidence: 99%
“…The effect size of PIs as impact criteria on clinical parameters, health problems, cost reduction and increase in profits is a measure of the direct impact the pharmacist had on patient health and quality of care system [ 68 , 69 , 75 , 175 , 231 , 232 ]. However, non-pharmacological treatment, care received from other health professionals, the placebo effect and remission of disease can all contribute to the results.…”
Section: Discussionmentioning
confidence: 99%
“…These could help in the early detection and prevention of ADR. Furthermore, based on the spontaneous reporting and active surveillance systems ( 47 ), the pharmacovigilance and drug and therapeutics committee could assist in monitoring the quality and safe use of medicines to improve medication safety ( 48 ). Another important part of the clinical pharmacist's role is medication reconciliation and supporting patient adherence ( 49 ), especially in geriatrics.…”
Section: Discussionmentioning
confidence: 99%